Apart from the antiviral property, mefenamic acid also showed promise in dengue treatment by targeting the NLRP3 inflammasome, a key driver of inflammation and vascular leakage in severe dengue cases like dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) [73,82,83]. The gene discussed is NLRP3; the disease is Dengue hemorrhagic fever.